Ginkgo Bioworks is building out their BioManufacturing Foundry platform which mimics the building of semiconductor foundries of yester year!

 78.63% of #GinkgoBioworks ( $DNA) stock is owned by #Institutional #investors.

Here are some of the major institutional shareholders:

ARK Investment Management LLC owns a significant number of shares in Ginkgo Bioworks Holdings, Inc. (NYSE: DNA). As of the most recent filings, they held 182,192,185 shares during the 3rd quarter of 2023. 

Additionally, in the 4th quarter, their holdings increased to 198,606,619 shares

Equitec Proprietary Markets LLC: Holds 672,488 shares (0.5% of the portfolio). Sumitomo Mitsui Trust Holdings Inc.: Holds 55,865,048 shares (2.595% of the portfolio).

(Note: M. Potter who served as President, Chief Executive Officer, and Chair of the board of Sumitomo Pharma America, and as the Chief Executive Officer of Sumitovant Biopharma, the parent company of five biotechnology companies, was added to the board of Ginkgo BioWorks on April 29th) Salem Investment Counselors Inc.: Holds 4,758,585 shares (0.221% of the portfolio). Vanguard Group Inc.: Holds 132,780,095 shares (6.169% of the portfolio). Lingotto Investment Management LLP: Holds 8,511,301 shares (0.402% of the portfolio). Additionally, during the previous two years, a total of 228 institutional investors and hedge funds held shares of Ginkgo Bioworks.

Some of the most heavily invested institutions include Baillie Gifford & Co., ARK Investment Management LLC, and Nikko Asset Management Americas Inc.. Institutional investors play a significant role in Ginkgo Bioworks’ ownership structure, with a mix of large investment firms and hedge funds holding substantial stakes in the company

Founded in 2008 by five #Scientists from #MIT, Ginkgo Bioworks is headquartered in #Boston. Their mission is to use #Biology to grow better products across diverse markets. They have developed a cell programming platform that enables the growth of biotechnology. Ginkgo’s platform allows for programming cells and designing organisms that behave in pre-defined ways. They work with various industries, from food to fragrance to pharmaceuticals. - - - - - - -

#Ginkgo collaborates with various organizations and companies like:

Pfizer

Pfizer has entered into a multi-target RNA discovery collaboration with Ginkgo Bioworks, cell engineering.

 In this partnership, Pfizer will leverage Ginkgo’s proprietary RNA technology to advance the discovery and development of novel RNA molecules across priority research areas. 

The collaboration is valued at a total of $331 million across three distinct programs, and Ginkgo Bioworks is entitled to potential downstream value in the form of royalties on sales

Ginkgo also collaborates with these partners:

#Motif #FoodWorks: Changing the future of #food. #Bayer: Designing #probiotics for plants. #Allonnia: Enabling bioremediation solutions. #Aldevron: Supporting the #Vaccine #SupplyChain. #Cronos Group: Unlocking potential in #Cannabinoids. #Synlogic: Engineering living #Medicines. #Moderna: Optimizing vaccine processes. #IARPA: Protecting valuable technology. #Robertet: Producing cultured ingredients. And more

Keep in mind the companies that collaborate with Ginkgo Bioworks to advance synthetic biology:

1. OneOne Biosciences

   , a French biotech startup, is developing a comprehensive suite of agricultural microbial solutions. They have partnered with Ginkgo Bioworks to leverage their robust ag biologicals infrastructure, biotechnological expertise, and Strain Optimization Services. The collaboration aims to accelerate OneOne’s research and product development in agricultural microbial solutions, including a novel solution for production and delivery of ag microbials through the OneOne Multiplier™1.

2. Synlogic: collaborates with Ginkgo Bioworks to develop a pipeline of novel “living” medicines based on engineered probiotics. They utilize Ginkgo’s cell programming platform to create innovative treatments.

3. Biogen:

    and Ginkgo Bioworks have announced a gene therapy collaboration. Their goal is to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors3.

4. Pfizer: Ginkgo Bioworks has a collaboration with Pfizer to advance the discovery and development of novel RNA molecules across priority research areas using Ginkgo’s proprietary RNA technology4.

Ginkgo has also acquired competitors like Zymergen etc, and have a serious "first mover" advantage in the field as they continue to build a "moat" around their business that few if any, will be able to copykey points:

1. Sustainability: Ginkgo’s platform enables leading pharmaceutical, food, and agriculture companies to develop more sustainable solutions. As the world increasingly looks to synthetic biology for emissions reduction and supply chain resilience, Ginkgo’s role becomes more critical.

2. Biosecurity:

   Ginkgo’s biosecurity business unit, Concentric, is working on building infrastructure to monitor biological threats. They collaborate with organizations like the Centers for Disease Control and Prevention (CDC) to enhance pathogen monitoring and develop tools to prevent misuse of engineered biology.

3. Employee Ownership and Care: Ginkgo is committed to thoughtful deployment of its platform. They’ve established a Caring Committee to assess potential impacts of their activities and integrate a Cost, Caring, and Risk Assessment (CCRA) process

4. How to invest in Robots and Robotics going forward, through the back door method!

5. "The rapid and complete resolution of aggressive MSS colorectal cancer tumors observed in this study is unprecedented in the field" says the author Dr. Kasi

MAGA- Antifa. Who is behind America's current crisis of extremist thought!

 As the far right Maga crowd truly believe their own government is the enemy,

and

As the far left Antifa crowd truly believe their own government is their enemy, and as different ethnic groups begin to look at other ethnic groups as their adversaries, one question begs to be asked by every freedom loving person, Where did that vile and disruptive influence originate. Where did it come from? I do not believe it began in America or it's government! Now, how would a true adversary attack the greatest democracy ever created,

who owns the greatest military ever created?

Well, you certainly can't confront their military directly.

That would be a national suicide for any adversary!

So, with proper planning by your intelligence services, you attack from within, using a superb weapon, democracy itself!

You concentrate your intelligence operation on the lynchpin of a great democracy,

FREE SPEECH! You use the new social media platforms, constantly, over years, maybe decades, to influence the population and you concentrate on the differences found in any democracy!

Free speech supplies all the bullets you need, words!

Those bullets are fired every minute, of every day, of every week, of every month of every year, by the guns of social media, such as: X (formerly Twitter), Facebook, Tik Tok (the young are easily led), You Tube, Whats App, Instagram, Reddit, Snapchat, pinterest, etc etc

You concentrate your fire directly at various groups who may distrust each other for various reasons, and you extend that mistrust continually, until, eventually, it resembles hatred. You concentrate your fire on the differences apparent in the two major political parties, and you work both sides.

Because these platforms allow your agents or bots to hide behind false names, false businesses, etc, they are the ideal guns pointed at the millions of American who use them every day, more and more.

I learned over many decades in Government, and in business, that, if you have a meeting of dozens of people on any subject, it will be the most ill-informed who speak the most and the loudest.

Now it is those who are loudest, that have the largest megaphones, supplied by social media platforms. These are the artillery, the big guns of your insidious attack. They have access to millions of ears, both young and old. Some may even have been recruited by your intelligence service, over years.

You stay relentless in your subtle and surreptitious attack until Democracy itself turns into a vortex like a black hole, and eventually swallows itself!

THAT, is how you attack the greatest democracy ever created on earth!

Who did it? Who's responsible?

These are the important questions we should all be asking, while we stay vigilant and aware that the adversaries of freedom have found our only weakness, and are exploiting that weakness every day!

HP @Retirefund

Is Cobalt the next Bull Market?

Investing notes: 

Cobalt is used in Lithium-ion Batteries of every size, from your SmartPhone to your ElectricCar or EV Energy storage units for Solar and Wind Power generation etc...

Cobalt, which has the element symbol Co, is a metal usually obtained through mining nickel, silver, lead, copper and iron. Discovered in the 18th century, it gave glass a deep blue color.

Today, cobalt's uses range from health and nutrition to industry. The US government treats cobalt as a strategic metal because a shortage would affect the economy, industry and defense of the country. Most cobalt used in the United States is imported.

Alloys, or mixtures of metals, make up half the cobalt used each year. Some alloys go into making jet engines and gas turbine engines. Another alloy, called Alnico, consists of of aluminum, nickel and cobalt and is strongly magnetic. Alnico magnets can be found in hearing aids, compasses and microphones. Cutting tools can be made with stellite alloys, which contain cobalt, chromium and tungsten.

Here are some other common uses for Cobalt (from Sciencing.com)

Alternative Energy

Cobalt improves the performance of rechargeable batteries and plays an important role in hybrid electric vehicles.

Orthopedic Implants

Cobalt alloys are used in orthopedic implants alongside titanium and stainless steel. The Idaho Cobalt Project states that approximately 70 percent of hip replacements use cobalt-chrome femoral stems.

Radiation Therapy and Sterilization

Cobalt-60, a radioactive form of the element, can treat some forms of cancer. The substance can also sterilize medical supplies.

Nutrition

Cobalt chloride, sulfate, acetate or nitrate can correct mineral deficiency in grazing animals living on cobalt-deficient soil. Cobalt is an essential part of vitamin B12.

Art Material

Cobalt salts are used to produce vivid shades of blue in porcelain, glass, pottery and tiles.

However, in today's "clean Energy" environment, it is the advent of large scale electrical storage, EV Batteries, Smart phones and other energy storage endeavors, that are making Cobalt a "Go To" commodity of the 21st century.  In many Lithium-ion batteries, there is more cobalt than lithium. 

There are many options to invest in Cobalt so do some homework

Disclosure: As a lead in to this market potential we like a broad brush and so we have bought

Cobalt 27 Capital Corp

TSXV  :  KBLT

 

We have also bought shares in one smallcap miner of Cobalt as a potential takeover target. We are investigating other avenues into this market.

Stock Markets do not like Tradewars - Is your Retire Fund in Jeopardy?

Is your Retire.Fund in jeopardy of a severe downturn in Stocks

You recently retired, or will retire in the next few years, but you are still heavily invested in the stock markets because that is where the growth has come from for the past 10 or so years.

  Did you take a beating in 2008? Do you even remember what happened that year? Maybe you didn't start saving/investing until late in your career, and you feel you need a bit more!

 Maybe it's time you considered "solidifying" the investments you still have.

Paper profits are great, until they are not! A sudden reversal in stock prices can wipe out 50% of your portfolio.  It can happen really fast these days as the Algos take over the selling, and markets drop like a rock! If that happens this year,(and this writer believes it will), then you may be left trying to decide to "stay in" to try and recoup your losses, or cash out with 20-50% less profit. If such an event occurs, it maybe a decade before you recoup those losses.

To this date the Nasdaq has returned, year to date, over 19%  "THAT" my friends is a great return on investment! The SP500 has returned almost as much YTD!

If your Index Funds are up over 15%, then congratulations, because, I believe, it won't happen again for years to come.  I sincerely do not believe that retirees or those nearing retirement, "will ever see" returns like this again!!!

If you are over 50 or need the money in your portfolio for retirement, if you don't have another 10-15 years to make up losses and cannot afford a downturn in stock prices (or bond prices for that matter see: Bonds) then maybe you should consider the wise advice of the foremost investor in modern history, Mr. Warren Buffett, who famously said:

Remember, "Cash" is also a Position and, at this juncture, it may be the best position!At this writing, we are mostly in cash, with a few exceptions.

Good luck, and be careful!  

Your Retire.Fund depends on it!

Avoiding Index Funds this year may be a good strategy for your Retire Funds

Individual Stocks VS Index Funds in 2019

2019 does not bode well for Stock Indexes and therefore, Index funds.  Buying Index funds has been the go-to investment of individual investors (and some institutional investors) for years now.  Since 2009, many have done very well with this simple strategy which has outdone many money managers over that time.

2019 may be different for a number of reasons! This bull market we have enjoyed since 2009, is getting very long in the tooth and 2019 is beginning to look like the end is in sight.

The macro picture is a mishmash of poor decisions and poor leadership from Central Banks and world leaders alike. The news is dominated by trade war talks, Walls, Brexit, German (read Euro) downturn, and Debt, beyond anything we have witnessed in the past. Real war cannot be dismissed either as the USA and North Korea are at a stalemate, and (nuclear armed) India and Pakistan are shooting down each others fighter jets, to the cheers of their domestic audiences.

With Britain on the verge of a "no deal" Brexit, Italy may be becoming a financial basket case, German output is inching into negative territory, and in France, the Macron government has done nothing to right that ship.

Some believe that, Deutsche Bank may well be the "Lehman Brothers" of the Euro zone this year as creditors close in and a bailout partner is not in sight. The two largest economies on the planet, USA and China are at serious odds over trade AND both are in serious DEBT!

As the USA begins to withdraw from the world under this administration, it owes $22 Trillion dollars and that debt is now growing at 1.5 Trillion per year under Trump.

There are two ways to handle such a debt burden, 1: Default
2: reduce the dollar to a nickel.  There is no other way to pay down such a massive debt! (my bet is that, if it were entirely up to Mr. Trump, he would pick door number 1)

There are now more refugees on the move across the world than WW2 and most countries are putting up barriers to entry. Euro zone countries from Spain to Greece are doing whatever they can to keep out refugees, instead of welcoming them. Climate change, inept governments and wars are the reasons for such a migration.

Witness the debacle in the USA on the southern border as this president continues to threaten to shut down government if he does not get his wall. This argument is a hideous sidelight to what is truly going on in the world. This same administration seems to admire despots while scorning democracy, whether it is in it's own constitution or that of valuable allies.

The USA has now walked away from trade agreements, peace treaties and most recently, a nuclear arms agreement with Russia. None of these things bode well for markets, or indeed, humanity, going forward, but the pied Pipers of Wall Street keep on playing!

On a lesser, and personal financial note, while most index funds have very low fees, they are paid annually, and therefore, add up over time, eating into profits.  As the value of your investments go up, so do your fees. This is a built in strategy that will eventually eat away at your gains. If these investments go down, the fund still gets paid, every year!

Conversely, Buying individual stocks is now usually done online for less than $10 per trade! (One time). When an index tumbles, not all stocks are included. Some stocks actually go up at such times.

 The drawback:

Now you have to do homework!  Stocks are not index funds! They require you to do some investigating of your own, unless, of course, you want to keep all your money in cash, gold and silver, and buried in your back yard!

Investing in Domain names has been quite lucrative for many investors!

Why Invest In Domain Names?

• Domains are the real estate of the world wide web. Like other real estate assets, location is a big deal. The best location for a web address is, far and away, the .com domain!
• To this date, the .com extension has been the most sought after extension, followed by .net and .org however in the past several years many other extensions have come online, and some have found six and seven figure values, especially individual country domains.
• Now there are numerous extensions with words like ,fund, .money, .sex, .store, well, you get the picture!
  
  Investments in web domain names has grown and there seems to be no end in sight for this rush to own a piece of the Web! 
•  
• In early 2019, the Web Address Fund .com sold (for a second time) for an estimated value of 2.5 million dollars. The domainName, Retire .Com fetched $2 Million when sold several years ago. The value is not only found in the easy marketing of such addresses, but also in the fact that each of those terms are valuable search terms showing up on major search engines like Google and Yahoo millions of times, and, unbeknown to the mass public, the .com is the "default" address for all searches.
•  
• It makes sense to own valuable search terms and a domain that is easily marketed and understood.  To that end, we are offering these three domains as a package, if the asking price is reached.
  

 
These 3 Retire Fund Domains on sale NOW
as a package!

RetireFund.com  
RetireFund.net 
RetireFund.org
 
3 premium web addresses for 1 price!

See: RETIREFUND.com now to buy or place a bid!
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -


More Domains on Auction Here!

Neo Lithium's 3Q project is one of the purest, and largest Li projects in the world today!

              There are MicroCaps and then there are:

                            "MicroCaps"!

 

Neo Lithium's 3Q project has the lowest impurities of "any" Lithium Brine project in the world, and is the 8th largest in size!

Company Highlights

• One of the highest-grade lithium brine assets in the world combined with the lowest critical impurity content of any known salar making it ideal for well-known and simple evaporation processing
• 8th largest lithium deposit in the world today!
• 100% ownership - The only Lithium company that owns an entire salar of this size without competitors or third parties
• Fully permitted to feasibility- EIA well advanced and expected to be finalized in Q1/Q2 2019
• Strong cash position and robust shareholder register

 

Experienced board and management focused on the Lithium sector.

CEO, Waldo Perez, was the original founder and past CEO of Lithium Americas.
Chairman, Constantine Karayannopoulos was the director of Lithium Americas and an original founder of Neo Materials, now Molycorp.
Board and management members have strong experience in business development and capital markets.

Right in the heart of the Lithium Triangle, the 3Q Project is located in Catamarca Province, Argentina the largest lithium producing and mining-friendly province in Argentina. Neo is situated between the truly bid dogs of Lithium production!

The 3Q Project has one of the highest-grade lithium brine projects in the world, with a large salar and lithium brine lake covering more than 150km2 and the Company controls more 350km2 in and around the complex. The 3Q Project is 100% owned by Neo Lithium.

The Company has obtained environmental permitting to complete exploration and the pilot plant and has also obtained the easement agreement to access the project for future construction at the project site.

Update: As of this writing, Feb 18th 2019, the Pilot plant is delivered and is being put in place at 3Q! 

We believe Neo Lithium is a prime takeover target in 2019  

Disclosure: We own Shares in Neo Lithium!

Question: Do you?

The first technological advance in the detection of atherosclerosis, heart disease and stroke in over 100 years awaiting FDA approval!

  (ED Note: We first posted this article 11 months ago, and feel it is even more relevant now with FDA Approval pending)

Lexington Bio Sciences (LexingtonBioSciences.com)

CSE-LNB or OTC-LXGTF 

Heart Disease and Heart Attacks are the number one killer of North Americans, and most people, worldwide. Nearly 1 in 3 deaths in the USA alone are attributed to Heart Attack and Stroke!

For 50% of these people, their "first" indication of a problem is a massive heart attack.  They have no warning whatsoever.

 

Though taking blood pressure and heart rates coupled with ultrasound techniques will sometimes indicate a problem, the fact remains that, only in 50% of all cases do these indicators work. Now, wouldn't it be great if there was a "Non-invasive" way of determining, with a lot more accuracy, if heart disease is prevalent in a patient, "before" the onset of a heart attack? Hey, wouldn't it be great if that test was no more bother than simply taking your blood pressure is?

Well, now there is such a device, currently in Clinical Trials, after 15 years of research and development in California Universities. Lexington BioSciences "HeartSentry" can measure something that has never been measured properly before. Endothelium

Endothelium, are the cells that line all arteries and are critical to the prevention of atherosclerosis, heart disease and stroke, the two leading causes of deaths worldwide (17.5 million people every year). 

The significant value of measuring endothelial function is supported by many peer-reviewed studies.

For ease of use this new, life saving technology has been incorporated into a simple blood pressure cuff.  Utilizing both blue tooth and cloud technology, the device to provide up-to-date, accurate readings of a patients complete cardiovascular health via electronic monitoring.

As you might expect, this is a significant development in a  multi-billion dollar market, and all the patents and the technology are owned by a MicroCap Business, owned and operated by PHD's

 

LexingtonBioSciences

 

 

 

 

 

As Crypto Currencies rise and begin to dominate investors thinking, Crypto Domain names are gaining popularity!

Whether you agree or disagree that Digital Assets like Crypto Currencies have value, you cannot escape the facts!

9 years ago Bitcoin was selling under $1 Dollar.

Today, (ups and downs aside) it sells around $6400!


That, my friends is an extreme jump in an investment!


As all Cryptos have increased

in price (for instance Ethereum Classic is up from a few cents to $14) Investors everywhere are wondering how they can get an edge in this new form of investing.

And, as more and more Banks and Businesses increase their Blockchain knowledge (and hire Crypto and Blockchain experts) to investigate how they can more securely transfer money and accounts worldwide, there is another avenue of Crypto investments that may have escaped the attention of mainstream investors.

  That is the area of Crypto Domain names (Web Addresses)

Namepros.com lists the top ten CryptoDomains sold Here to date!

As you can see, the domain Eth.Com lead the pack at a cool $2,000,000

As you can also see in that list, many other Crypto domains like CryptoWorld and CryptoBank sold in 6 figures!

Even the lesser Dot com domains sold in 5 figures.

Domainers have been scooping up these domains by the hundreds, because they know that the new Crypto business startups will be looking for online addresses and possibly new branding.

So, Are DomainNames.Money?

You Bet they are!!!

About Lexington Bio Sciences - Early Detection and prevention of Heart Disease and Stroke!

The Endothelium: Getting to the “Heart” of Cardiovascular Disease

Despite positive developments in medication and lifestyle changes to reduce risk factors associated with cardiovascular disease (CVD) and atherosclerosis (plaque build-up in arteries), stroke and heart attack remain the leading cause of death worldwide.  Innovation in medical care and medical devices will likely play a central role in improving long term cardiovascular health outcomes. Over the past several years, Lexington Biosciences has focused on the health of the endothelium, which is the critical inner lining covering all blood vessels throughout the body.  We are excited to introduce the HeartSentry device as an important endothelial health measurement tool, which can serve as an early predictor in the cardiovascular disease process. From the heart to the tiniest capillary, endothelial cells form the innermost lining of the entire circulatory system. Cumulatively called the endothelium, it is composed of a single layer of cells which are critical to vascular health, and which may function as a kind-of “built-in” sensor for the vascular system. They act to guide the arteries to dilate or constrict under stress or other external stimuli. Disruption of normal endothelial function is known to be a precursor to CVD and atherosclerosis. In short, as the vascular system becomes burdened with atherosclerosis, the endothelial cells stop working as well as they did as before, which can provide a key signal that the health of the cardiovascular system has been adversely affected. A dysfunctional endothelium can be one of the earliest signs that plaque is accumulating inside arteries, which can be non-invasively observed as an inability to dilate effectively under different flow conditions or environmental stresses. Once the endothelium is disrupted and plaque starts to accumulate, it’s usually there for good – barring medical intervention. If left untreated over time, plaque will eventually increase until it blocks the artery or breaks free to enter the circulatory system. The result is typically either a heart attack or a stroke. The good news is that medication can help improve cardiovascular disease and decrease risk of catastrophic events like heart attack or stroke. Therefore monitoring endothelial function may offer an essential approach to prevent cardiovascular disease and guide treatment. This is why we have developed and positioned HeartSentry as a front line cardiovascular diagnostic device. While the above is widely acknowledged in medical circles, most of the general population aren’t aware of the importance of the endothelium because few people undergo testing for it. Testing modalities are currently limited, and often involve procedures which can be hard to perform such as flow-mediated dilation (FMD) to evaluate endothelial function. FMD measures the endothelial response during reactive hyperemia (changes in blood flow). However, it has shortcomings in that it is difficult to perform and is subject to a high degree of user dependent test variability. While the literature supports endothelial assessment as being a valuable precursor of CVD and atherosclerosis, many of the tests to evaluate it can be invasive or difficult to perform and, all too often, are not ordered until the disease has undergone significant progression. We believe that a non-invasive, reproducible, and instantaneous test of endothelial function could be a game-changer for long term cardiovascular disease prevention.   Lexington Biosciences has developed an easy-to-use device that will enable users to obtain endothelial function measurements as easily as stepping on a scale or measuring blood pressure or temperature, that can be done in a clinic or potentially even from the comfort of home.  We are optimistic that HeartSentry can help to fill this important need, advancing the field to help prevent cardiovascular diseases like heart attack and stroke.

More From Lexington BioSciences

Lexington BioSciences Inc. aims to become a leader in the development of cardiovascular measurement solutions proposed for common clinical applications with the potential for future home use. 
 

Please visit our website to watch our video, find out more about us, and subscribe to Twitter or Facebook to receive the latest news, newsletters, blog posts and more.
Join the conversation about our exciting HeartSentry product

 

 

 

 

Domains are a 21st Century Investment!

Xomains.com

Retirefunds - Target Dated Retirement Funds - Web Domain

The Domain Name, RetireFunds.com is now available for purchase!

 

RETIREFUNDS.COM

 

What are your clients doing?

AFTER WORK!!

 

 

 

Graphene Engineering and Nanomanufacturing Domains

You can now own or lease these premium Web Addresses for your business.

GrapheneEngineering.com

(The Web Domain)
is for sale or lease!

So is:
Nanoman.com

There is Gold in Web Domain Names

Are Domain Names Gold you ask?

Are DomainNames.Money you ask?

You bet they are!

Domainers from every Country on this planet know full well the value of a good Web Address.

And we have some Premium Domains for sale!


Go to:  Http://DomainNames.Money now,
to see the list of DomainNames available!

To buy or bid on the Web Domain of your choice!

Domain Broker is Epik.com
(A Third party broker)
Will handle all sales transactions!

IBC Advanced Alloys Corp details

IBC Advanced Alloys Corp.

TSX VENTURE : IB
OTCQX : IAALF

Description

IBC Advanced Alloys Corp. (IBC), formerly International Beryllium Corporation, is a Canada-based Company engaged in the development and manufacturing of advanced alloys, in particular beryllium alloys and specialty copper alloys. It also focuses on beryllium mineral exploration. IBC can be used in its pure form or combined with other metals to form unique alloys for essential applications for the nuclear, aerospace, medical, automotive, electronics and defence industries. It operates in three aspects: manufacturing, research and mineral exploration. It provides manufacturing and support services, including casting and master alloy products, cast and forged billet products, semi-continuous cast input billets and wrought products. It operates in copper alloys division and beryllium aluminium division. IBC owns a 100% interest in the Boomer mine located in the Lake George beryllium district. IBC US Holdings, Inc., Freedom Alloys, Inc., Nonferrous Products, Inc. are its subsidiaries.

More from Reuters »

Officers and directors

Anthony Dutton		President, Chief Executive Officer, Director
Simon J. Anderson		Chief Financial Officer, Secretary
Chris Huskamp		Acting President of IBC Engineered Materials Corp
Ray White		President of IBC Engineered Materials
Mark Wolma		President of IBC Copper Alloys
General David R. Heinz		Chief Operating Officer, Director
James Patrick Malone		Vice President - Nuclear Fuels
Dal S. Brynelsen		Independent Director
Jerry Michael Jarvis		Independent Director
Alastair S Neill		Independent Director

Full list on Reuters »

Contact Information

• 
  
  IBC Advanced Alloys Corp.
  Ian Tootill
  Director of Corporate Communications
  (604) 685-6263 ext. 110
  Email: itootill@ibcadvancedalloys.com
  Website: www.ibcadvancedalloys.com
  
  

  IBC Subsidiaries:

  Freedom Alloys, Inc.
  IBC Engineered Materials Corporation
  IBC Mineral Properties, Inc.
  IBC US Holdings, Inc.
  NF Industries, Inc.
  Nonferrous Products, Inc.
  Rare Earths Limited, LLC
  Specialloy Copper Alloys LLC